| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |